Omega-3 Fatty Acids for Preterm Infants Harmonization Initiative
The objective of the Omega-3 Fatty Acids for Preterm Infants Harmonization Initiative was to determine the impact of a neonatal enteral supplementation with omega-3 fatty acids on bronchopulmonary dysplasia and neonatal outcomes in very preterm infants.
Overview
- Acronym
- N3PI-HI
- Start - End Year
- 2022 - 2023
- Investigators
-
- Contacts
-
Relevant Papers
Marc I, Lavoie PM, McPhee AJ, Collins CT, Simonyan D, Pronovost E, Guillot M, Gould JF, Mohamed I, Beltempo M, Boutin A, Fortier I, Sullivan TR, Moore L, Makrides M. Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis. BMJ Open. 2023; 13(7):e076223. PUBMED 37518076
Participating Studies
| Acronym | Name | Study design | Countries |
|---|
Harmonization Initiatives Included
| Acronym | Name |
|---|
Harmonization Protocols
| Name | Type | Approach | Studies | Participants | Variables |
|---|
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Last Update: 2024-12-04T11:51:29.048